Increased leucocyte count could predict coronary artery calcification in patients free of clinically apparent cardiovascular disease

Turk Kardiyoloji Dernegi Arsivi

Volumn 40, Issue 3, 2012, Pages 223-228

  Korkmaz, Levent ^a   Kul, Selim ^b   Korkmaz, Ayça Ata ^a   Akyüz, Ali Riza ^c   Aǧaç, Mustafa Tarik ^b   Erkan, Hakan ^b   Acar, Zeydin ^b   Adar, Adem ^b   Erkuş, Muslihittin Emre ^b   Çelik, Şükrü ^b  

^a Adana Numune Training and Research Hospital   (Turkey)

^b Trabzon Ahi Evren Thorasic and Cardiovascular Surgery Training and Research Hospital   (Turkey)

^c Akcaabat Hackali Baba State Hospital   (Turkey)

Author keywords

Atherosclerosis blood; Biological markers blood; Calcium; Coronary artery disease epidemiology; Risk factors

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SMOKING;

AGE FACTORS; AGED; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; SMOKING;

EID: 84864196690     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2012.37801     Document Type: Article

References (25)

1. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990;11 Suppl E:3-19.
2. Santos RD, Nasir K. Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis? Atherosclerosis 2009;205:349-56.
3. Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 2010;56:98-105.
4. Ardehali R, Nasir K, Kolandaivelu A, Budoff MJ, Blumenthal RS. Screening patients for subclinical atherosclerosis with non-contrast cardiac CT. Atherosclerosis 2007;192:235-42. (Pubitemid 46729718)
5. Achenbach S, Raggi P. Imaging of coronary atherosclerosis by computed tomography. Eur Heart J 2010;31:1442-8.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
7. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest 1981;68:1394-403. (Pubitemid 12194392)
8. Mehta J, Dinerman J, Mehta P, Saldeen TG, Lawson D, Donnelly WH, et al. Neutrophil function in ischemic heart disease. Circulation 1989;79:549-56. (Pubitemid 19087705)
9. Weissmann G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980;303:27-34. (Pubitemid 10073397)
10. Ludwig PW, Hunninghake DB, Hoidal JR. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet 1982;2:348-50.
11. Hamirani YS, Pandey S, Rivera JJ, Ndumele C, Budoff MJ, Blumenthal RS, et al. Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis 2008;201:1-7.
12. Redberg RF, Rifai N, Gee L, Ridker PM. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 2000;36:39-43. (Pubitemid 30466109)
13. Hunt ME, O'Malley PG, Vernalis MN, Feuerstein IM, Taylor AJ. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001;141:206-10. (Pubitemid 32128724)
14. Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002;106:1189-91. (Pubitemid 34988633)
15. Reilly MP, Wolfe ML, Localio AR, Rader DJ; Study of Inherited Risk of Coronary Atherosclerosis. C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851-6. (Pubitemid 37254874)
16. Kullo IJ, McConnell JP, Bailey KR, Kardia SL, Bielak LF, Peyser PA, et al. Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension. Am J Cardiol 2003;92:56-8.
17. Iribarren C, Gross MD, Darbinian JA, Jacobs DR Jr, Sidney S, Loria CM. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study. Arterioscler Thromb Vasc Biol 2005;25:216-21.
18. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-8.
19. Jenny NS, Brown ER, Detrano R, Folsom AR, Saad MF, Shea S, et al. Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2010;209:226-9.
20. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009;2:692-700.
21. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70.
22. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-5.
23. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 2008;52:17-23.
24. Shareghi S, Ahmadi N, Young E, Gopal A, Liu ST, Budoff MJ. Prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr 2007;1:155-9.
25. Preis SR, Hwang SJ, Fox CS, Massaro JM, Levy D, Hoffmann U, et al. Eligibility of individuals with subclinical coronary artery calcium and intermediate coronary heart disease risk for reclassification (from the Framingham Heart Study). Am J Cardiol 2009;103:1710-5.